Harrow Health Inc (NASDAQ:HROW)
| 9.97 Delayed Data As of 4:00pm ET |  +0.24 / +2.47%Today’s Change | 5.40 Today|||52-Week Range 12.99 | +15.39% Year-to-Date |
Latest HROW News | Press Releases
No recent news for Harrow Health Inc.
Today’s Trading
| Previous close | 9.73 |
| Today’s open | 9.79 |
| Day’s range | 9.63 - 10.01 |
| Volume | 6,823 |
| Average volume (3 months) | 110,288 |
| Market cap | $261.2M |
Data as of 4:00pm ET, 09/28/2022
Growth & Valuation
| Earnings growth (last year) | -432.87% |
| Earnings growth (this year) | +54.35% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +48.30% |
| P/E ratio | NM |
| Price/Sales | 3.19 |
| Price/Book | 23.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ORMPOramed Pharmaceutica... | +0.09 | +1.36% |
| AVEOAveo Pharmaceuticals... | +0.38 | +4.87% |
| --China Health Group I... | 0.00 | 0.00% |
| --Photocure ASA | 0.00 | 0.00% |
Data as of 4:00pm ET, 09/28/2022
Financials
| Next reporting date | November 15, 2022 |
| EPS forecast (this quarter) | -$0.01 |
| Annual revenue (last year) | $72.5M |
| Annual profit (last year) | -$18.0M |
| Net profit margin | -24.85% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Nashville, Tennessee |
Forecasts
